Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Apolipoprotein H induces sex-specific steatohepatitis and gut dysbiosis during chronic hepatitis B infection. | iScience | 2023 | 36852272 | PubTator, text mining | PubMed |
| Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases. | Viruses | 2023 | 36851782 | PubTator, text mining | PubMed |
| Key Factors for "Fishing" NTCP as a Functional Receptor for HBV and HDV. | Viruses | 2023 | 36851726 | PubTator, text mining | PubMed |
| Inhibition of Hepatitis B Virus (HBV) by Tachyplesin, a Marine Antimicrobial Cell-Penetrating Peptide. | Pharmaceutics | 2023 | 36839994 | PubTator, text mining | PubMed |
| The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. | Pharmaceutics | 2023 | 36839686 | PubTator, text mining | PubMed |
| Alzheimer's Disease: An Updated Overview of Its Genetics. | Int J Mol Sci | 2023 | 36835161 | PubTator, text mining | PubMed |
| Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis. | Biomedicines | 2023 | 36830921 | PubTator, text mining | PubMed |
| Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro. | Sci Rep | 2023 | 36823196 | PubTator, text mining | PubMed |
| Liver's influence on the brain through the action of bile acids. | Front Neurosci | 2023 | 36816113 | PubTator, text mining | PubMed |
| Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients. | Acta Pharm Sin B | 2023 | 36815037 | PubTator, text mining | PubMed |
Mechanistic in vitro studies indicate that the clinical drug-drug interactions between protease inhibitors and rosuvastatin are driven by inhibition of intestinal BCRP and hepatic OATP1B1 with minimal contribution from OATP1B3, NTCP and OAT3. | Pharmacol Res Perspect | 2023 | 36811234 | PubTator, text mining | PubMed |
| Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions. | Clin Mol Hepatol | 2023 | 36800698 | PubTator, text mining | PubMed |
| Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug. | Front Oncol | 2023 | 36798821 | PubTator, text mining | PubMed |
| The role of FOXA family transcription factors in glucolipid metabolism and NAFLD. | Front Endocrinol (Lausanne) | 2023 | 36798663 | PubTator, text mining | PubMed |
| Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection. | Clin Mol Hepatol | 2023 | 36788759 | PubTator, text mining | PubMed |
| Active enterohepatic cycling is not required for the choleretic actions of 24-norUrsodeoxycholic acid in mice. | JCI Insight | 2023 | 36787187 | PubTator, text mining | PubMed |
The "humanized" N-glycosylation pathway in CRISPR/Cas9-edited Nicotiana benthamiana significantly enhances the immunogenicity of a S/preS1 Hepatitis B Virus antigen and the virus-neutralizing antibody response in vaccinated mice. | Plant Biotechnol J | 2023 | 36779605 | PubTator, text mining | PubMed |
| Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review. | ADMET DMPK | 2023 | 36778905 | PubTator, text mining | PubMed |
| Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies-A Critical Overview. | Nutrients | 2023 | 36771465 | PubTator, text mining | PubMed |
| Dietary Responses of Dementia-Related Genes Encoding Metabolic Enzymes. | Nutrients | 2023 | 36771351 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=26